(S1 (S (S (NP (NP (DT The) (NN inhibition)) (PP (IN of) (NP (VBN cultured) (JJ myoblast) (NN differentiation))) (PP (IN by) (NP (DT the) (JJ simian) (NN virus) (NP (CD 40) (JJ large) (NN T) (NN antigen))))) (VP (VP (VBZ occurs) (PP (IN after) (NP (NP (NN myogenin) (NN expression)) (CC and) (NP (NN Rb) (NN up-regulation))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN exerted) (PP (IN by) (NP (JJ transformation-competent) (JJ cytoplasmic) (NNS mutants))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (DT the) (JJ simian) (NN virus) (CD 40) (NP (NP (JJ large) (NN T) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN SVLT)) (-RRB- -RRB-)))) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NN C2) (NNS myoblasts)))))))))))) (. .)))
(S1 (S (S (NP (NP (NN SVLT) (NNS mutants)) (, ,) (ADJP (JJ defective) (PP (CC either) (PP (IN in) (NP (DT the) (NN Rb) (NN binding) (NN site))) (, ,) (PP (IN near) (NP (DT the) (JJ N-terminal) (NN end))) (, ,) (PP (IN in) (NP (NP (DT a) (NN region)) (SBAR (WHNP (WDT that)) (S (VP (VBZ affects) (NP (NP (NN binding)) (PP (TO to) (NP (NN p53))))))))) (, ,) (CC or) (PP (IN in) (NP (DT the) (JJ nuclear) (NN transport) (NN signal))))) (, ,)) (VP (VBD were) (ADVP (RB also)) (VP (VBN employed) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (DT the) (NN interference)) (VP (VBD was) (ADJP (RB especially) (JJ dependent) (PP (IN on) (NP (DT these) (JJ functional) (NNS domains))))))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (S (NP (NP (NP (JJ wild-type)) (PRN (-LRB- -LRB-) (NP (JJ wt)) (-RRB- -RRB-))) (NN SVLT)) (ADVP (RB strongly)) (VP (VBD inhibited) (NP (NP (DT the) (JJ terminal) (NN differentiation)) (PP (IN of) (NP (NN mouse) (NN C2) (NNS myoblasts)))))) (, ,) (CC but) (S (NP (DT this) (NN arrest)) (VP (VBD occurred) (ADVP (RB only)) (PP (IN after) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (NN myogenin)) (, ,) (NP (NP (DT an) (JJ initial) (NN step)) (PP (IN in) (NP (JJ biochemical) (NN differentiation))))))))))))))) (. .)))
(S1 (S (S (NP (CC Neither) (NP (DT the) (NN synthesis)) (CC nor) (NP (NP (DT some) (JJ basic) (NNS activities)) (PP (IN of) (NP (NN MyoD))))) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NN wt) (NN SVLT))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT these) (NNS transformants))) (, ,) (NP (NN mitogen) (NN depletion)) (VP (VBD elicited) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN Rb) (NN level)) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (JJ normal) (NN C2) (NNS cells))))))))))) (: ;) (S (NP (NN wt) (NN SVLT)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD promoted) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (DT a) (JJ large) (NN part)) (PP (IN of) (NP (DT the) (VBN induced) (NN Rb)))))))) (. .)))
(S1 (S (S (NP (NP (NNS Mutations)) (VP (VBG affecting) (NP (JJ nuclear) (NN transport)))) (VP (VBD were) (ADJP (ADVP (RB far) (RBR more)) (JJ critical) (PP (IN for) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (JJ myogenic) (NN differentiation))) (SBAR (IN than) (S (VP (VBD were) (NP (NP (DT those)) (VP (VBG affecting) (NP (DT the) (NN transforming) (NN potential))))))))))))))) (: ;) (S (NP (JJ cytoplasmic) (NN SVLT) (NN expression)) (VP (VBD was) (ADJP (RB fully) (JJ compatible) (PP (IN with) (NP (NP (DT the) (JJ terminal) (NN differentiation)) (PP (IN of) (NP (NN C2) (NNS cells)))))) (, ,) (PP (IN despite) (S (VP (VBG enabling) (S (NP (PRP them)) (VP (TO to) (VP (VB grow) (PP (IN in) (NP (JJ semisolid) (NN medium))) (, ,) (S (ADVP (RB thus)) (VP (VBG showing) (SBAR (IN that) (S (NP (DT the) (JJ myogenesis-inhibiting) (NN property)) (VP (MD can) (VP (VB be) (VP (VBN dissociated) (PP (IN from) (NP (NN transforming) (NN competence)))))))))))))))))) (. .)))
(S1 (S (S (NP (DT The) (VBG remaining) (NN SVLT) (NNS mutants)) (VP (VBD presented) (NP (NP (JJ different) (NNS degrees)) (PP (IN of) (NP (NP (NN ability)) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN differentiation)) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ tissue-specific) (NNS markers)) (PP (IN in) (NP (NNS transformants)))))))))) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ inhibiting) (NNS mutants)) (, ,) (PP (VBG including) (NP (DT the) (NN Rb) (NN binding) (NN site) (NN mutant))) (, ,)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB promote) (NP (NP (DT a) (JJR higher) (NN state)) (PP (IN of) (NP (NN Rb) (NN phosphorylation)))) (PP (IN than) (NP (NP (DT that)) (VP (VBN observed) (PP (IN in) (NP (CC either) (NP (JJ normal) (NNS cells)) (CC or) (NP (JJ cytoplasmic-SVLT) (NNS transformants))))))))))))) (. .)))
